Table 1 Baseline clinical characteristics of stroke patients without or with subsequent development of atrial fibrillation
Parameter | Stroke (N=227) | No AF (n=188) | AF (n=39) | P-value |
|---|---|---|---|---|
Age, years | 73 [63 to 80] | 73 [61 to 80] | 73 [69 to 80] | 0.072 |
Male sex (%) | 135 (59%) | 114 (61%) | 21 (54%) | 0.693 |
Heart Failure | 7 (3%) | 4 (2.1%) | 3 (7.7%) | 0.218 |
Hypertension (%) | 130 (57%) | 101 (53.7%) | 29 (74.4%) | 0.012 |
Diabetes (%) | 35 (15%) | 26 (13.8%) | 9 (23.7%) | 0.210 |
Vascular disease (%) | 95 (42%) | 77 (41.0%) | 18 (46.2%) | 0.560 |
TIA (%) | 49 (22%) | 45 (23.9%) | 4 (10.3%) | <0.001 |
New-onset atrial fibrillation | 39 (17%) | 0 (0.0%) | 39 (100.0%) | <0.001 |
Median time to AF onset/end follow-up | 3.2 [1.3 to 5.9]) | 9.7 [4.3 to 10.1] | 2.9 [1.2 to 6.4] | <0.001 |
P duration | 116 [106 to 126] | 116 [106 to 122] | 118 [111 to 131] | 0.224 |
QRSd | 78 [68 to 90] | 86 [78 to 94] | 88 [75 to 99] | 0.880 |
Pvm | 0.16 [0.13 to 0.20] | 0.16 [0.13 to 0.20] | 0.13 [0.11 to 0.19] | 0.006 |
P duration/Pvm | 711 [560 to 893] | 694 [547 to 862] | 801 [586 to 1046] | 0.009 |